If the response to the COVID-19 pandemic taught us anything, it is that in building a patient-centered future, the pharmaceutical industry plays a key role. It has to constantly find new ways to customize medicines while researching and developing new tools and drugs. By embracing disruptive technologies like 3D printed drugs, artificial intelligence guided therapies, and preventive medicine while working with regulatory agencies, the pharmaceutical companies will benefit from having a digital revolution. Furthermore, emerging markets will have a more significant say in the global pharmaceutical market in the coming years.
Here are the top 20 largest pharmaceutical companies in the world.
| Rank | Company | Market cap |
| 1. | Johnson & Johnson | $428.66 billion |
| 2. | Roche | $320.41 billion |
| 3. | Pfizer | $219.39 billion |
| 4. | Eli Lilly | $208.99 billion |
| 5. | Novartis | $207.70 billion |
| 6. | AbbVie | $202.60 billion |
| 7. | Merck | $191.67 billion |
| 8. | Novo Nordisk | $187.83 billion |
| 9. | Astrazeneca | $152.28 billion |
| 10. | Bristol-Myers Squibb | $145.80 billion |
| 11. | Amgen | $136.50 billion |
| 12. | Sanofi | $130.37 billion |
| 13. | CVS Health | $110.49 billion |
| 14. | GlaxoSmithKline | $104.30 billion |
| 15. | CSL | $103.10 billion |
| 16. | Gilead Sciences | $83.62 billion |
| 17. | Moderna | $83.25 billion |
| 18. | Merck KGaA | $80.61 billion |
| 19. | Bayer | $59.43 billion |
| 20. | Jiangsu Hengrui Medicine | $58.51 billion |
